Why no fixed planning timeline exists
Multiple myeloma is not one clinical situation. A newly diagnosed patient being assessed for first-line therapy, a patient whose disease has relapsed after several lines of treatment, and a patient considering a stem cell transplant or a clinical trial each require different records and different specialist input. That is why any promise of a set planning period would be misleading.
Planning abroad adds a second layer: the receiving hospital has to understand your disease from documents rather than from seeing you in clinic. Haematology teams typically work from blood and urine results, bone marrow reports, imaging and a clear treatment history. When those are incomplete, the team has to ask for more before it can say anything useful about suitability or next steps. Each exchange adds time, and the number of exchanges depends on your case.
So the honest answer to "how long" is that the planning phase runs until the treating haematology team has enough information to give a view. Your job is to shorten that by sending a well-organised summary first, then the supporting documents the team actually requests.
The records that most affect the pace
The single biggest factor you influence is whether your file lets a haematologist reconstruct your disease course quickly. A useful starting set usually includes the pathology or bone marrow report that established the diagnosis, recent full blood count and biochemistry, myeloma-specific markers such as serum and urine protein electrophoresis with immunofixation, serum free light chains, and beta-2 microglobulin and albumin for staging. Imaging reports, cytogenetic and FISH results, and a dated list of every treatment you have received, with responses and any toxicities, matter just as much.
You do not need to send everything at once. A short summary with the diagnosis, current stage or risk category as recorded by your own team, current treatment or treatment-free interval, your main question, and a list of the documents you hold is enough for a first look. The receiving team can then tell you what it still needs. Sending a complete archive before anyone has asked can slow things down rather than speed them up, because the relevant items get buried.
Two practical points reduce delay. First, ask your current hospital for reports in English where available, or arrange a certified translation of key documents; whether a particular Chinese hospital requires translation is a question to confirm with that hospital. Second, keep dates consistent across documents so the team can see the sequence of diagnosis, treatment and response.
What the receiving team must confirm before any plan
A haematology team reviewing you from abroad cannot confirm suitability, treatment availability or a plan from records alone. It will want to establish the diagnosis and current disease status, understand what treatments you have already had and how you responded, and judge whether you are medically fit to travel and to receive further therapy. Some of that requires tests that may need to be repeated or added in China, and the treating clinicians decide which.
It also matters that you separate two different questions. One is whether a records-based opinion is possible: a specialist reviews your documents and gives a view while you remain at home. The other is whether you will be accepted for treatment in China, which is the hospital's decision after its own assessment. A review does not establish acceptance, and it does not establish access to any particular therapy, transplant programme or clinical trial.
Ask directly what the team needs to reach a view, and what it cannot conclude without seeing you. That answer tells you more about timing than any general estimate.
Questions that shorten the planning phase
The fastest way to waste weeks is to ask vague questions and receive vague answers. Put specific questions in writing to the hospital or the coordinating team, and ask for written replies you can compare.
Useful questions include: which documents do you need before a haematologist can review my case; will the review be records-based only, or does it require an in-person visit; which tests would likely need repeating in China and who decides that; what information do you need about my previous treatment responses; and what would you need from me before you could indicate whether treatment here is possible. Ask also how the hospital communicates decisions and who your point of contact is.
Keep a simple log of what you sent, when, and what came back. When several people are involved, a dated log prevents the same document being requested twice and makes gaps visible.
How ChinaSpecialistCare fits in, and what it does not decide
ChinaSpecialistCare provides information and non-clinical coordination for international patients considering care in China. For a myeloma enquiry, the team can check the diagnosis, records and your main question, identify missing information and suggest a relevant next step. That initial case review is free and is not a diagnosis or a promise of acceptance.
Where a records-based specialist opinion would help, an optional proxy consultation can take your records to a relevant hospital specialist while you remain at home. A multidisciplinary review involving more than one specialty may be arranged for complex cases, with the scope and fee agreed first. Specialist matching and appointment coordination, and later hospital and treatment coordination after a hospital accepts you, are separate services. Hospital consultation fees, tests, treatment and medicines are paid to the hospital or provider, and our coordination fees are separate.
What none of this changes is the clinical decision. Suitability, treatment choice, whether a transplant or trial is appropriate, and acceptance all belong to the treating hospital and its licensed clinicians. Coordination can make the exchange of records and questions more efficient; it cannot make a clinical answer arrive sooner than the evidence allows.
A realistic way to sequence your preparation
Start with your own team. Ask your haematologist for a short summary letter covering diagnosis, current disease status, treatments received and responses, and any planned next step. That letter, plus your most recent blood and marrow results, is the most useful first package.
Then make one clear request to the receiving side: a records-based view of whether further treatment in China is worth exploring, and what information is missing. Wait for that reply before arranging translations, travel or appointments. If the reply asks for specific documents, send only those, labelled and dated.
Only after the hospital indicates that a visit or treatment discussion is appropriate should you plan travel, and even then confirm with the hospital what must happen on arrival, which tests will be repeated, and how decisions will be communicated. Ask the hospital about its own scheduling and reporting arrangements rather than relying on general assumptions, because these vary by institution and by case.
If your disease is progressing or you have urgent symptoms, local assessment takes priority over overseas planning. Do not delay care while documents are assembled.
To begin, send a brief summary through the enquiry form, email or WhatsApp; the initial review is free, and you can share fuller records after first contact. The next step is simply to describe your diagnosis, current status and the question you want answered.
Sources & scope of this guide
References and official service information relevant to this guide.
- Related treatment reference
- Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ®) - NCI
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.
